BioPharm International-05-01-2013

BioPharm International

Should Regulation of Combination Products Become More Centralized in Europe?

May 01, 2013

European Beat

26

5

While there are those who want combination products to be controlled by a centralized pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a decentralized device-focused approach.

Report from Brazil

May 01, 2013

Global News

26

5

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Facility Trends: Modularization and Single Use

May 01, 2013

Features

26

5

BioPharm International spoke with INTERPHEX 2013 conference-session presenters to gain insight on trends in facility and process design.

BioPharm International, May 2013 Issue (PDF)

May 01, 2013

Issue PDF

26

5

Click the title above to open the BioPharm International May 2013 issue in an interactive PDF format.

BioPharm International, May 2012 Issue (PDF)

May 01, 2012

Issue PDF

26

5

Monoclonal Antibodies : Developing an Alternative Polishing Step